There were 123 press releases posted in the last 24 hours and 393,703 in the last 365 days.

New OTCBB Listing: First China Pharmaceutical

September 3, 2010 (FinancialWire) (Investrend Information Syndicate) (Go to http://www.financialwire.net/?s=lstngsnws for other listings news articles.) — First China Pharmaceutical Group, Inc. (FCPG.OB), a communications systems technology company, is officially listed on the Over-the-Counter Bulletin Board exchange, effective August 30, trading in units of 100.

From First China Pharmaceutical’s August 6, 2010, Form 10-Q filing for the quarterly period ending June 30, 2010:

“First China Pharmaceutical Group, Inc., formerly E-Dispatch Inc. (the “Company”), a development stage company, was incorporated on July 31, 2007 under the laws of the State of Nevada.  Initial operations have included organization and incorporation, target market identification, new product development, marketing plans, and capital formation.  A substantial portion of the Company’s activities has involved developing a business plan and establishing contacts and visibility in the marketplace.  The Company has not generated any revenues since inception.  The Company plans to engage in cell phone based taxi dispatch systems.”

Complete filings on all U.S. exchange listed reporting companies are accessible via the SEC website (at http://www.sec.gov/edgar/searchedgar/webusers.htm).

The OTC Bulletin Board (OTCBB) provides access to more than 3,300 securities.  The OTCBB is a regulated quotation service that displays real-time quotes, last-sale prices, and volume information in over-the-counter (OTC) equity securities. An OTC equity security generally is any equity that is not listed or traded on NASDAQ or a national securities exchange. OTCBB securities include national, regional, and foreign equity issues, warrants, units, American Depositary Receipts (ADRs), and Direct Participation Programs (DPPs).

=========

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ssryrsyr] [lstngsnws] [addtllstngs] [otcblltnbrd]